U.S. Biochip Product & Services Market, By Type (Products (Microarrays, Reagents & other Consumables, Others), Services), By Application (Drug Discovery, Life Science Research, IVD Tests, Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 20

U.S. Biochip Product & Services Market, By Type (Products (Microarrays, Reagents & other Consumables, Others), Services), By Application (Drug Discovery, Life Science Research, IVD Tests, Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Surgical Equipment are used for diagnosis of infectious diseases, respiratory diseases, cancer, and for personalized treatment. There are three types of biochips namely DNA microarray, protein microarray, and microfluidic chip. Increasing number of clinical trials along with technological advancements are expected to aid in growth of the market. Furthermore, increasing product approvals and increasing incidence of chronic diseases is also expected to assist the growth of the market during the forecasted period.
Key features of the study:
This report provides in-depth analysis of the U.S. Biochip Products and Services market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the U.S. Biochip Products and Services market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abbott Laboratories, Agilent Technologies, Affymetrix Inc., Beckman Coulter, Inc., Illumina Incorporated, Life Technologies Corporation, Randox Laboratories Ltd., Surfix B.V, and AYOXXA Biosystems GmbH.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The U.S. Biochip Products and Services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. Biochip Products and Services market
Detailed Segmentation:
U.S. Biochip Products and Services Market, By Type:
Products
Microarrays
Reagents & other Consumables
Others
Services
U.S. Biochip Products and Services Market, By Application:
Drug Discovery
Life Science Research
IVD Tests
Others
Company Profiles
Abbott Laboratories *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Agilent Technologies
Affymetrix Inc.
Beckman Coulter, Inc.
Illumina Incorporated
Life Technologies Corporation
Randox Laboratories Ltd.
Surfix B.V
AYOXXA Biosystems GmbH
“*” marked represents similar segmentation in other categories in the respective section.